Skip to content Skip to footer

Consider CanceRx As Your Innovation Partner

Bring Your Research
Into Clinical Reality

By synchronizing financial innovation with scientific advancement, CanceRx will close a critical gap between discovery and drug development. CanceRx will license in promising research and in exchange will provide financial, clinical trial development, pilot manufacturing and regulatory expertise. CanceRx will negotiate development and marketing with drug companies. Royalties will be shared with intellectual property inventors.

Partner with CanceRx


By submitting this form, you are consenting to receive marketing emails from: CanceRx. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Many brilliant researchers are wary about the complexity of clinical development. CanceRx brings this expertise to the table. If you are interested in how partnering benefits your cancer research program, we would love to talk with you.”

Cody Gibbons, Chief Operating Officer, CanceRx LLC
cancerx_white_transparent-sm

No information contained on this website should be construed as a forward-looking statement.

CanceRx Foundation, Inc., is an IRS approved tax-exempt public charitable foundation under Sec. 501(c)(3) of the U.S. Internal Revenue Code.

CanceRx® is a registered trademark.

To learn more, please call or email:

CanceRx Foundation, Inc.

4830 W Kennedy Blvd, Suite 600
Tampa, FL 33609-2584

Phone: (813) 776-0000

Email: donations@cancerx-foundation.org

CanceRx © 2025. All Rights Reserved.
Go to Top